Next Article in Journal
Characterization of a Bioflocculant (MBF-UFH) Produced by Bacillus sp. AEMREG7
Next Article in Special Issue
14-3-3γ Regulates Lipopolysaccharide-Induced Inflammatory Responses and Lactation in Dairy Cow Mammary Epithelial Cells by Inhibiting NF-κB and MAPKs and Up-Regulating mTOR Signaling
Previous Article in Journal
A Structural Overview of RNA-Dependent RNA Polymerases from the Flaviviridae Family
Previous Article in Special Issue
Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(6), 12958-12985;

Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents

Chemokine Biology Research Laboratory, Programa Institucional de Investigación en Cancer de Mama, Mexico DF 04510, Mexico
Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico DF 04510, Mexico
Author to whom correspondence should be addressed.
Academic Editor: Kamal D. Moudgil
Received: 7 December 2014 / Revised: 3 May 2015 / Accepted: 8 May 2015 / Published: 8 June 2015
(This article belongs to the Special Issue Mechanism of Action and Applications of Cytokines in Immunotherapy)
Full-Text   |   PDF [1298 KB, uploaded 8 June 2015]   |  


Chemokines are a burgeoning family of chemotactic cytokines displaying a broad array of functions such as regulation of homeostatic leukocyte traffic and development, as well as activating the innate immune system. Their role in controlling early and late inflammatory stages is now well recognized. An improper balance either in chemokine synthesis or chemokine receptor expression contributes to various pathological disorders making chemokines and their receptors a useful therapeutic target. Research in this area is progressing rapidly, and development of novel agents based on chemokine/ chemokine receptors antagonist functions are emerging as attractive alternative drugs. Some of these novel agents include generation of chemokine-derived peptides (CDP) with potential agonist and antagonist effects on inflammation, cancer and against bacterial infections. CDP have been generated mainly from N- and C-terminus chemokine sequences with subsequent modifications such as truncations or elongations. In this review, we present a glimpse of the different pharmacological actions reported for CDP and our current understanding regarding the potential use of CDP alone or as part of the novel therapies proposed in the treatment of microbial infections and cancer. View Full-Text
Keywords: chemokine; chemokine receptors; cytokines; inflammation; cancer; microbial infections; peptides chemokine; chemokine receptors; cytokines; inflammation; cancer; microbial infections; peptides

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Valdivia-Silva, J.; Medina-Tamayo, J.; Garcia-Zepeda, E.A. Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents. Int. J. Mol. Sci. 2015, 16, 12958-12985.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top